Questions discussed in this category
ASCENT-07 data recently did not meet the endpoint for progression-free survival for sacituzumab govitecan as a first-line treatment post-endocrine the...
Or would you wait for other information/data before incorporating T-DXd in perioperative treatments? Harbeck et al., PMID 41130363
268582693126929268952689426479
Papers discussed in this category
The New England journal of medicine, 2025 Dec 10
BMJ open, 2025 Aug 27
The New England journal of medicine, 2025 Oct 29
JAMA, 2025 Dec 12
Cancer, 2009-04-15
Lancet, 2022 Aug 06
JAMA oncology, 2023 Sep 21
The New England journal of medicine, 2024 Dec 12
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014 Nov 04
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2018 Oct 07
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017 Jan 04
JAMA, 2025 Mar 18
JAMA, 2025 Mar 18